Medpace Holdings, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Share Repurchases This table provides certain information with respect to our monthly repurchases of the Company’s common stock during the second quarter of fiscal year 2025: Period Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plan Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan April 1, 2025, through April 30, 2025 1,198,556 $ 294.00 10,952,164 $ 992,421,570 May 1, 2025, through May 31, 2025 233,447 $ 292.30 11,185,611 $ 924,185,657 June 1, 2025, through June 30, 2025 322,261 $ 303.88 11,507,872 $ 826,256,169 Total 1,754,264 $ 295.59 11,507,872 All share repurchases were made using cash resources and executed pursuant to established Rule 10b5-1 trading plans. Our share repurchases may occur through open market purchases or negotiated transactions. The above table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards. We returned $518.5 million to shareholders in the form of share repurchases in the second quarter of fiscal year 2025. Refer to Note 1 – Basis of Presentation of the Notes to Condensed Consolidated Financial Statements (Part I, Item 1 of this Form 10-Q) for further discussion regarding share repurchases. Use of Proceeds from Registered Securities Not applicable. Item 3. Defaults Upon Senior Securities None. -27- Table of Contents Item 4. Mine Safety Disclosures Not applicable.